Orifarm owner confirms: We are exploring the possibility of a co-investor
”As a family and owners, we want to ensure that all conditions are in place for the further development of Orifarm,” says owner and chairman of the board Hans Bøgh-Sørensen.
Chairman of the board Hans Bøgh-Sørensen, who together with his family owns pharmaceutical group Orifarm Group, confirms to MedWatch’s Danish sister media, KapitalWatch, that the family is investigating the possibility of getting a co-investor on board.
The confirmation follows media Insidebusiness’ news yesterday that Orifarm has hired the international corporate finance company, Rothschild, to sell an ownership stake in Orifarm.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
